Amedeo Smart

Free Medical Literature Service


 

Amedeo

Gynecology

  Free Subscription

28.09.2026

2 Acta Obstet Gynecol Scand
1 AJR Am J Roentgenol
2 Am J Obstet Gynecol
2 BMC Cancer
3 BMJ
1 Br J Cancer
1 Cancer Lett
1 Eur J Cancer
5 Eur J Obstet Gynecol Reprod Biol
5 Fertil Steril
1 Gynecol Endocrinol
4 Gynecol Oncol
1 Hum Reprod
2 Int J Cancer
6 Int J Gynaecol Obstet
1 JAMA
2 Obstet Gynecol
1 PLoS Comput Biol
3 PLoS One
1 Radiology



    Acta Obstet Gynecol Scand

  1. ZHANG T, Yang J, Shi X, Liu Z, et al
    Pebbled mosaic-like heterogeneous echogenicity in ovarian immature teratomas and correlation of ultrasound patterns with pathological grades.
    Acta Obstet Gynecol Scand. 2026 Sep 25. doi: 10.1111/aogs.70360.
    >> Share

  2. MOEN IH, Johnsen SL, Kessler J, Vietheer A, et al
    Diagnostic performance and feasibility of classifying placental umbilical cord insertion during routine prenatal ultrasound.
    Acta Obstet Gynecol Scand. 2026 Sep 23:10.1111/aogs.70359.
    >> Share


    AJR Am J Roentgenol

  3. MABUD TS, Sajan A, Naser-Tavakolian K, Young L, et al
    Short-Term Safety of Uterine Fibroid Embolization Versus Myomectomy Subtypes: A Propensity-Weighted National Claims Analysis.
    AJR Am J Roentgenol. 2026 Sep 23. doi: 10.2214/AJR.26.35737.
    >> Share


    Am J Obstet Gynecol

  4. XIE Y, Li J, Ye T
    Reverse Causation, Detection, and Adiposity in the Association Between Early Life Adversity and Polycystic Ovary Syndrome (Letter-to-the-Editor).
    Am J Obstet Gynecol. 2026 Sep 19:S0002-9378(26)00503.
    >> Share

  5. WALLIS B, Gimbel LA, Sanders J
    Interpreting Mood Symptoms and Contraceptive Discontinuation in Observational Research (Reply to Letter-to-the-Editor).
    Am J Obstet Gynecol. 2026 Sep 19:S0002-9378(26)00494.
    >> Share


    BMC Cancer

  6. ZIDI S, BenAbdelmoumenMardassi B, Sahraoui G, Almawi WY, et al
    PDCD1 gene polymorphisms linked with altered risk of female-specific hormone-dependent cancers: a systematic review and meta-analysis.
    BMC Cancer. 2026;26:1124.
    >> Share

  7. AYDIN O, Dogan HGY, Sonusen SD, Erciyestepe M, et al
    The effect of adding ovarian function suppression to adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive, HER2-positive breast cancer who have undergone neoadjuvant therapy: a single-center experience.
    BMC Cancer. 2026;26:1140.
    >> Share


    BMJ

  8. MEAIDI A
    We still do not know the answers to fundamental questions about menopause.
    BMJ. 2026;394:e100911.
    >> Share

  9. BERGGREEN J, Pourhadi N, Wood-Kurland H, Lokkegaard E, et al
    Contemporary menopausal hormone therapy and thrombotic disease: nationwide nested case-control study.
    BMJ. 2026;394:e100688.
    >> Share

  10. MURPHY F
    Abortion: South Korea to approve mifepristone.
    BMJ. 2026;394:e100937.
    >> Share


    Br J Cancer

  11. ALBERS FE, Swain CT, Dashti SG, Rinaldi S, et al
    Inflammatory biomarkers and risk of postmenopausal oestrogen receptor-positive breast cancer: a case-cohort analysis.
    Br J Cancer. 2026 Sep 19. doi: 10.1038/s41416-026-03624.
    >> Share


    Cancer Lett

  12. SANTHAMMA B, Chacon J, Deemer E, Stary D, et al
    Endometriosis from initiation to innovation: Immune microenvironments, clonal lesion biology, and the emerging therapeutic pipeline.
    Cancer Lett. 2026;660:218845.
    >> Share


    Eur J Cancer

  13. BERARDI E, van Driel WJ, Hermans RHM, Gaarenstroom KN, et al
    Corrigendum to "MRI in advanced ovarian cancer: Multicentre MISSION trial" [Eur J Cancer 238 (2026) 116614].
    Eur J Cancer. 2026;248:117055.
    >> Share


    Eur J Obstet Gynecol Reprod Biol

  14. SONKUSARE S, Prabhu L, Shetty P, Naik P, et al
    Corrigendum to "Comparison of proteinuria assessment methods and their association with maternal-fetal outcomes in preeclampsia" [Eur. J. Obstetr. Gynecol. Reproduct. Biol. 311 (2025) 114010].
    Eur J Obstet Gynecol Reprod Biol. 2026 Sep 25:115447.
    >> Share

  15. HARRISON C, Westby M, Family H, Ijaz S, et al
    Availability and effectiveness of interventions to support healthcare professionals exposed to patient pregnancy and neonatal loss: a systematic review.
    Eur J Obstet Gynecol Reprod Biol. 2026;327:115456.
    >> Share

  16. POLIO A, Esposito A, Bosquet JG, Goodheart MJ, et al
    Improved overall survival with combined adjuvant chemotherapy and radiation in stage I uterine carcinosarcoma: A national cancer database study.
    Eur J Obstet Gynecol Reprod Biol. 2026;327:115448.
    >> Share

  17. GAO L, Wang F, Ji Q, Chen C, et al
    Construction and verification of a prediction model for gestational diabetes mellitus complicated with gestational hypertension based on a specialized disease research database.
    Eur J Obstet Gynecol Reprod Biol. 2026;327:115449.
    >> Share

  18. ZEEVI G, Romano A, Barzilay M, Chen I, et al
    Association between timing of surgical retrieval and organ involvement after uterine perforation by an intrauterine device.
    Eur J Obstet Gynecol Reprod Biol. 2026;327:115446.
    >> Share


    Fertil Steril


  19. Diagnosis and treatment of luteal phase deficiency: a Committee Opinion.
    Fertil Steril. 2026;126:633-639.
    >> Share

  20. WANG T, Li Y, Tong R
    Machine learning prediction of euploid pregnancy loss: validation is not prevention.
    Fertil Steril. 2026;126:758.
    >> Share

  21. DI SPIEZIO SARDO A, Manzi A, Zizolfi B, Giampaolino P, et al
    Corrigendum to 'The step-by-step hysteroscopic treatment of patients with vaginal and complete uterine septum with double cervix (U2bC2V1)' (Fertil Steril 2026;116:602-4).
    Fertil Steril. 2026 Sep 23:S0015-0282(26)01750.
    >> Share

  22. FOUKS Y, Morse B, Stern C, Kirshenbaum M, et al
    FMR1-Associated Diminished Ovarian Reserve: Reduced Oocyte Yield Without Loss of Per-Embryo Ploidy.
    Fertil Steril. 2026 Sep 22:S0015-0282(26)01791.
    >> Share

  23. ESKANDARION S, Eliwa J, Soto DE, Bennett RD, et al
    Precision Surgery for Colorectal Deep Endometriosis: Strategies for Complete Excision Without Segmental Resection.
    Fertil Steril. 2026 Sep 21:S0015-0282(26)01788.
    >> Share


    Gynecol Endocrinol


  24. Expression of Concern: Metabolic changes in overweight and obese women above 35 years using Ethinylestradiol/drosperinone combined contraceptive pills: a 3-year case-control study.
    Gynecol Endocrinol. 2026;42:2733778.
    >> Share


    Gynecol Oncol

  25. EDWARDS CC, Turner KA, Dinkins KG, Ketch PW, et al
    A phase II study in newly diagnosed stage III/IV epithelial ovarian cancer evaluating carboplatin/taxol/pembrolizumab in patients receiving neoadjuvant chemotherapy followed by pembrolizumab maintenance with or without olaparib.
    Gynecol Oncol. 2026;213:68-71.
    >> Share

  26. SALINARO JR, Marketkar S, Haddock P, James N, et al
    Concordance between gastric HER2 scores for endometrial sampling versus hysterectomy specimens in endometrial cancer.
    Gynecol Oncol. 2026;214:1-6.
    >> Share

  27. O'CONNOR RM, Sinnott JA, Meade CE, Kanal SA, et al
    Association of community-level social vulnerability with county-level clinical trial access among ovarian cancer patients.
    Gynecol Oncol. 2026;213:95-101.
    >> Share

  28. MAH SJ, Seow H, Carter Ramirez DM, Eiriksson LR, et al
    Impact of palliative radiotherapy in patients with gynecologic malignancies on end-of-life outcomes.
    Gynecol Oncol. 2026;213:82-88.
    >> Share


    Hum Reprod

  29. DONNO V, Sachs-Guedj N, Devesa M, Garcia-Martinez S, et al
    The two-shot protocol. A randomized controlled trial of a novel two-injection ovarian stimulation strategy.
    Hum Reprod. 2026 Sep 25:deag142. doi: 10.1093.
    >> Share


    Int J Cancer

  30. VERHOEF L, Griffioen MS, Bleeker MCG, Hinrichs JWJ, et al
    Triage Performance of FAM19A4/miR124-2 Methylation: 18-Month Follow-Up Results From a Prospective Observational Study Within the Dutch Primary HPV-Based Cervical Screening Program.
    Int J Cancer. 2026 Jun 29. doi: 10.1002/ijc.70626.
    >> Share

  31. GORODNOVA TV, Sokolenko AP, Kotiv KB, Donskih RV, et al
    Randomized Prospective Comparison Between Neoadjuvant Mitomycin C Plus Cisplatin and Paclitaxel Plus Carboplatin in Patients With BRCA1-Associated Ovarian Cancer.
    Int J Cancer. 2026 Sep 25. doi: 10.1002/ijc.70750.
    >> Share


    Int J Gynaecol Obstet

  32. PRABHAKAR T, Saini B
    A Robson classification-based audit of cesarean section rates and public health implications in a tertiary care center in India.
    Int J Gynaecol Obstet. 2026 Sep 24. doi: 10.1002/ijgo.71362.
    >> Share


  33. RETRACTION: Reproductive Outcome after Letrozole versus Laparoscopic Ovarian Drilling for Clomiphene-Resistant Polycystic Ovary Syndrome.
    Int J Gynaecol Obstet. 2026 Sep 24. doi: 10.1002/ijgo.71388.
    >> Share


  34. RETRACTION: Preliminary Uterine Artery Ligation versus Pericervical Mechanical Tourniquet in Reducing Hemorrhage During Abdominal Myomectomy.
    Int J Gynaecol Obstet. 2026 Sep 24. doi: 10.1002/ijgo.71387.
    >> Share


  35. RETRACTION: Short-Term Metformin Treatment for Clomiphene Citrate-Resistant Women with Polycystic Ovary Syndrome.
    Int J Gynaecol Obstet. 2026 Sep 24. doi: 10.1002/ijgo.71389.
    >> Share

  36. NAJOR AJ, Thappa S, Lee EM, Shin JH, et al
    Baseline cardiovascular risk before myomectomy versus hysterectomy for fibroids.
    Int J Gynaecol Obstet. 2026 Sep 22. doi: 10.1002/ijgo.71363.
    >> Share

  37. BENEDETTO C, Gulati M, Khadilkar SS, Maas AHEM, et al
    Menopause hormone therapy in women with cardiovascular risk factors or established ischemic heart disease: A joint FIGO and WHF position paper.
    Int J Gynaecol Obstet. 2026 Sep 22. doi: 10.1002/ijgo.71356.
    >> Share


    JAMA

  38. RODGERS L
    Remove the Fallopian Tubes If the Opportunity Arises, ACOG Says in New Ovarian Cancer Prevention Guidance.
    JAMA. 2026 Sep 25. doi: 10.1001/jama.2026.19503.
    >> Share


    Obstet Gynecol

  39. ALLEN A, Schembri M, Parvataneni R, Waetjen LE, et al
    Effectiveness of Laparoscopic Radiofrequency Ablation of Uterine Leiomyomas Compared With Myomectomy on Symptoms and Health-Related Quality of Life.
    Obstet Gynecol. 2026 Sep 22. doi: 10.1097/AOG.0000000000006432.
    >> Share

  40. WERNER EF
    Milestones in Motion: Gestational Diabetes.
    Obstet Gynecol. 2026 Sep 22. doi: 10.1097/AOG.0000000000006433.
    >> Share


    PLoS Comput Biol

  41. ELNAGGAR JH, Lammons JW, Ardizzone CM, Aaron KJ, et al
    Predicting bacterial vaginosis incidence using artificial neural networks.
    PLoS Comput Biol. 2026;22:e1014768.
    >> Share


    PLoS One

  42. KHAZEM H, Zemler RS, David LV, Reder D, et al
    BCAM-AKT2 fusion protein promotes unfolded protein response driven oncogenic signaling in SKOV3 epithelial ovarian cancer cell line.
    PLoS One. 2026;21:e0357882.
    >> Share

  43. KRATZ JW, Velho RV, Bock S, Sehouli J, et al
    Evaluating the impact of cannabinoid extracts on chronic pain and quality of life in endometriosis patients - a pilot study.
    PLoS One. 2026;21:e0356768.
    >> Share

  44. GHOSH S, Bag AK, Mukherjee S, Cao X, et al
    A quantitative treatment assessment for optimizing combined virotherapy-chemotherapy regimens against HPV-induced cervical cancer.
    PLoS One. 2026;21:e0342672.
    >> Share


    Radiology

  45. HINDMAN N, Tong A, Huang K
    How I Do It: Identifying Signs to Differentiate Uterine Sarcoma (Leiomyosarcoma) from Leiomyomas at MRI.
    Radiology. 2026;320:e252877.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016